CURRENT AFFAIRS

2021

Please wait while the activity loads.
If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled.

If loading fails, click here to try again

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]

Serum Institute of India will begin manufacturing which among the following vaccines in India from September 2021?

A	Pfizer
B	Moderna
C	J & J
D	Sputnik V

Explanation:

Detailed explanation-1: -Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).

Detailed explanation-2: -COVOVAX - SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine - Serum Institute Of India. SERUM INSTITUTE OF INDIA PVT.

Detailed explanation-3: -DTaP Vaccine Serum Institute of India has initiated development of acellular pertussis vaccine containing purified antigenic components of B. Pertussis viz. Pertussis Toxoid (PT), Filamentous Haemagglutinin (FHA), Pertactin.

Detailed explanation-4: -COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).

There is 1 question to complete.